India's primary market anticipates a significant influx of healthcare IPOs next year, with an estimated ₹20,000 crore in public issues expe...

Peak XV’s $2.85 billion eighth fund under Sequoia Capital was announced in 2022 – for investing in venture, growth and Southeast Asia. Of t...

Fortis Healthcare and Healthcare Global Enterprises hit a record highs on Tuesday, Apollo Hospitals and KIMS did so last week. All leading ...

True North (erstwhile India Value Fund Advisors or IVFA) is the largest shareholder in Cloudnine with about 36% stake, while other investor...

Among the firms that have secured the regulator's clearance include Lifestyle retail brand FabIndia; Bharat FIH, a subsidiary of FIH Mobile...

PharmEasy is ready to take a valuation cut of up to 25% to bag $200 million from investors amidst the ongoing funding winter, sources told ...

Of Rs 300 crore fresh issuance, the company is planning to use about Rs. 95 crores for the repayment of the debt, Rs 117.90 crore for setti...

Likely to sell 30% stake; True North, Sequoia will dilute part stake.

While Cloudnine may be raising Rs 2,500-3,500 crore, Medanta is looking to mop up about Rs 2,000 crore and the Park Group of Hospitals is t...

Three Indian fintech firms have IPOs coming up soon, but face unique challenges related to their revenue models, foreign ownership, and inc...

From Byju's acquisition spree to Nykaa inching closer to its IPO and Goat Brand Labs securing new funds, here's a quick look at the top tec...

True North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...